CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer?Mirat Shah, Vered Stearns, Maria Raquel Nunes|PubMed|2018Cited by 132
U.S. FDA Drug Approvals for Breast Cancer: A Decade in ReviewShaily Arora, Julia A. Beaver, Sakar Wahby et al.|Clinical Cancer Research|2021Cited by 73
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot StudyMirat Shah, Benjamin W. Corn, Phyllis Dvora Corn et al.|JCO Oncology Practice|2021Cited by 25
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in ReviewShaily Arora, Julia A. Beaver, Preeti Narayan et al.|Clinical Cancer Research|2021Cited by 23